ReviewExpert review of hematology2014
Ibrutinib: a paradigm shift in management of CLL.
Talha Badar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ReviewExpert review of hematology2014
Talha Badar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.